Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.

The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function

Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481 · see citing works

Adult sibling experience, roles, relationshhips and future concerns - a review of the literature in learning disabilities

(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486 · see citing works

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · see citing works

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response

Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924 · see citing works

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238 · see citing works

Decreased bioavailability of vitamin D in obesity

Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204 · see citing works

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,067 · see citing works

Macrophages, inflammation, and insulin resistance

Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · see citing works

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · see citing works

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · see citing works

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529 · see citing works

What we talk about when we talk about fat

Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · see citing works

Dynamics of fat cell turnover in humans

Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · see citing works

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,770 · see citing works

The global NAFLD epidemic

Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,696 · see citing works

Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression

Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J. L., Tavera-Mendoza, L. E., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,640 · see citing works

Insulin and insulin resistance:

Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,521 · see citing works

Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

Hotamışlıgil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,344 · see citing works

Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease

Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322 · see citing works

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296 · see citing works

Relationship between Adipocyte Size and Adipokine Expression and Secretion

Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · see citing works

Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation

Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · see citing works

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.

Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191 · see citing works

Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis

Okorodudu, D. O., Jumean, M. F., Montori, V. M., Romero‐Corral, A., Somers, V. K., Erwin, P. J., & López-Jiménez, F. A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.5 · Cited by 1,183 · see citing works

Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects

Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · see citing works

Epidemiology of Non-Alcoholic Fatty Liver Disease

Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · see citing works

Adiponectin: More Than Just Another Fat Cell Hormone?

Chandran, M., Phillips, S. A., Ciaraldi, T. P., & Henry, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2442 · Cited by 1,007 · see citing works

Beyond insulin resistance in NASH: TNF-α or adiponectin?

Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942 · see citing works

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 917 · see citing works

Interleukin-6 induces cellular insulin resistance in hepatocytes.

Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · see citing works

Non‐alcoholic fatty liver disease

Angulo, P., & Lindor, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 838 · see citing works

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R. A., Bugianesi, E., & Gastaldelli, A. (2013) · Nutrients · doi:10.3390/nu5051544 · Cited by 824 · see citing works

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis

Feldstein, A. E., Wieckowska, A., López, R., Liu, Y., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 711 · see citing works

Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

Crespo, J., Cayón, A., Fernández-Gil, P. L., Hernández‐Guerra, M., Mayorga, M., Domínguez‐Díez, A., Fernández-Escalante, J. C., & Pons‐Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693 · see citing works

Evidence for alteration of the vitamin D-endocrine system in obese subjects.

Bell, N. H., Epstein, S., Greene, A. S., Shary, J., Oexmann, M. J., & Shaw, S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111971 · Cited by 685 · see citing works

Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women

Snijder, M. B., van Dam, R. M., Visser, M., Deeg, D. J. H., Dekker, J. M., Bouter, L. M., Seidell, J. C., & Lips, P. T. A. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0216 · Cited by 681 · see citing works

The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults

Parikh, S. J., Edelman, M., Uwaifo, G. I., Freedman, R. J., Semega‐Janneh, M., Reynolds, J. C., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031398 · Cited by 659 · see citing works

Visceral fat: A key mediator of steatohepatitis in metabolic liver disease

van der Poorten, D. K., Milner, K.-L., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 633 · see citing works

Characterizing the profile of obese patients who are metabolically healthy

Primeau, V., Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-È., Messier, V., SLADEK, R. M., & RABASA-LHORET, R. P. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 630 · see citing works

Tumor Necrosis Factor-α Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation

Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · see citing works

Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance

Forouhi, N. G., Luan, J., Cooper, A., Boucher, B. J., & Wareham, N. J. (2008) · Diabetes · doi:10.2337/db08-0593 · Cited by 613 · see citing works

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I. L., Torjesen, P. A., Birkeland, K. I., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 605 · see citing works

Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597 · see citing works

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 590 · see citing works

Adipocyte extracellular matrix composition, dynamics and role in obesity

Mariman, E. C. M., & Wang, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0263-4 · Cited by 559 · see citing works

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 531 · see citing works

Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study

Cheng, S. C., Massaro, J. M., Fox, C. S., Larson, M. G., Keyes, M. J., McCabe, E. L., Robins, S. J., O’Donnell, C. J., Hoffmann, U., Jacques, P. F., et al. (2009) · Diabetes · doi:10.2337/db09-1011 · Cited by 522 · see citing works

Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice

Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · see citing works

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

Bhala, N. B., Angulo, P., van der Poorten, D., Lee, E., Hui, J. M., Saracco, G. M., Adams, L. A., Charatcharoenwitthaya, P., Topping, J. H., Bugianesi, E., et al. (2011) · Hepatology · doi:10.1002/hep.24491 · Cited by 450 · see citing works

Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2005) · Gut · doi:10.1136/gut.2005.071118 · Cited by 439 · see citing works

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

Targher, G., Bertolini, L., Scala, L., CIGOLINI, M., Zenari, L., Falezza, G., & Arcaro, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.04.002 · Cited by 438 · see citing works

The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications

Earthman, C. P., Beckman, L. M., Masodkar, K., & Sibley, S. D. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.119 · Cited by 432 · see citing works

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis

Wieckowska, A., McCullough, A. J., & Feldstein, A. E. (2007) · Hepatology · doi:10.1002/hep.21768 · Cited by 422 · see citing works

Adiponectin and its receptors in non-alcoholic steatohepatitis

Kaser, S., Moschen, A. R., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R., & Tilg, H. (2004) · Gut · doi:10.1136/gut.2003.037010 · Cited by 412 · see citing works

Human fat cell lipolysis: biochemistry, regulation and clinical role.

Arner, P. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.004 · Cited by 401 · see citing works

25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age

Hyppönen, E., Boucher, B. J., Berry, D. J., & Power, C. (2007) · Diabetes · doi:10.2337/db07-1122 · Cited by 388 · see citing works

Vitamin D3 in fat tissue

Blum, M., Dolnikowski, G. G., Seyoum, E., Harris, S. S., Booth, S. L., Peterson, J., Saltzman, E. J., & Dawson‐Hughes, B. (2008) · Endocrine · doi:10.1007/s12020-008-9051-4 · Cited by 366 · see citing works

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?

Chitturi, S., Farrell, G. C., Frost, L., Kriketos, A. D., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 363 · see citing works

Expression of CYP3A4, CYP2B6, andCYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes

Drocourt, L., Ourlin, J.-C., Pascussi, J., Maurel, P., & Vilarem, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201323200 · Cited by 356 · see citing works

Oligomerization State-dependent Activation of NF-κB Signaling Pathway by Adipocyte Complement-related Protein of 30 kDa (Acrp30)

Tsao, T., Murrey, H. E., Hug, C., Lee, D. H., & Lodish, H. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200312200 · Cited by 352 · see citing works

The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation

Wensveen, F. M., Valentić, S., Šestan, M., Turk Wensveen, T., & Polić, B. (2015) · European Journal of Immunology · doi:10.1002/eji.201545502 · Cited by 348 · see citing works

Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy

Chen, S., Law, C. S., Grigsby, C. L., Olsen, K., Hong, T., Zhang, Y., Yeghiazarians, Y., & Gardner, D. G. (2011) · Circulation · doi:10.1161/circulationaha.111.032680 · Cited by 343 · see citing works

Adipose Tissue Collagen VI in Obesity

Pasarica, M., Gawrońska‐Kozak, B., Burk, D. H., Remedios, I., Hymel, D., Gimble, J., Ravussin, É., Bray, G. A., & Smith, S. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0947 · Cited by 338 · see citing works

Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.

Kong, J., & Li, Y.-C. (2006) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00410.2005 · Cited by 327 · see citing works

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

Barchetta, I., Angelico, F., Ben, M. D., Baroni, M. G., Pozzilli, P., Morini, S., & Cavallo, M. G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-85 · Cited by 321 · see citing works

Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance

Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 315 · see citing works

Vitamin D signalling in adipose tissue

Ding, C., Gao, D., Wilding, J. P. H., Trayhurn, P., & Chen, B. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512003285 · Cited by 314 · see citing works

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis

Pοlyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 310 · see citing works

Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis

Giordano, A., Murano, I., Mondini, E., Perugini, J., Smorlesi, A., Severi, I., Barazzoni, R., Scherer, P. E., & Cinti, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038638 · Cited by 297 · see citing works

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation

Roth, C. L., Elfers, C., Figlewicz, D. P., Melhorn, S. J., Morton, G. J., Hoofnagle, A. N., Yeh, M. M., Nelson, J. E., & Kowdley, K. V. (2011) · Hepatology · doi:10.1002/hep.24737 · Cited by 289 · see citing works

NF-κB Activation, Rather Than TNF, Mediates Hepatic Inflammation in a Murine Dietary Model of Steatohepatitis

Peňa, A. D., Leclercq, I. A., Field, J., George, J., Jones, B., & Farrell, G. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 288 · see citing works

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats

Abramovitch, S., Dahan-Bachar, L., Sharvit, E., Weisman, Y., Tov, A. B., Brazowski, E., & Reif, S. (2011) · Gut · doi:10.1136/gut.2010.234666 · Cited by 286 · see citing works

Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273 · see citing works

Meta-analysis: vitamin D and non-alcoholic fatty liver disease

Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F. L., Potter, J. J., Koteish, A. A., Clark, J. M., Güallar, E., & Hernáez, R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12377 · Cited by 272 · see citing works

Metabolically healthy but obese individuals

Karelis, A. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61531-7 · Cited by 269 · see citing works

Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity

Botella-Carretero, J. I., Álvarez‐Blasco, F., Villafruela, J. J., Balsa, J. A., Vázquez, C., & Escobar-Morreale, H. F. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.05.009 · Cited by 263 · see citing works

Role of Adiponectin in the Protective Action of Dietary Saturated Fat Against Alcoholic Fatty Liver in Mice * #

You, M., Considine, R. V., Leone, T. C., Kelly, D. P., & Crabb, D. W. (2005) · Hepatology · doi:10.1002/hep.20821 · Cited by 259 · see citing works

Serum Leptin Levels in Patients With Nonalcoholic Steatohepatitis

Uygun, A., Kadayıfçı, A., Yeşilova, Z., Erdil, A., Yaman, H., Saka, M., Deveci, S., Bağcı, S., Gülşen, M., Karaeren, N., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03297.x · Cited by 256 · see citing works

The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells

Gascon-Barré, M., Demers, C., Mirshahi, A., Néron, S., Zalzal, S., & Nanci, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50176 · Cited by 254 · see citing works

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial

Sharifi, N., Amani, R., Hajiani, E., & Cheraghian, B. (2014) · Endocrine · doi:10.1007/s12020-014-0336-5 · Cited by 248 · see citing works

Vitamin D Receptor Attenuates Renal Fibrosis by Suppressing the Renin-Angiotensin System

Zhang, Y., Kong, J., Deb, D. K., Chang, A., & Li, Y. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080872 · Cited by 242 · see citing works

D-livering the message: The importance of vitamin D status in chronic liver disease

Kitson, M. T., & Roberts, S. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.033 · Cited by 238 · see citing works

Leptin in nonalcoholic fatty liver disease: A narrative review

Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.012 · Cited by 235 · see citing works

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

Wunderlich, F. T., Ströhle, P., Könner, A. C., Gruber, S., Tovar, S., Brönneke, H. S., Juntti-Berggren, L., Li, L.-S., van Rooijen, N., Libert, C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.011 · Cited by 229 · see citing works

Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus

Barchetta, I., Carotti, S., Labbadia, G., Gentilucci, U. V., Muda, A. O., Angelico, F., Silecchia, G., Leonetti, F., Fraioli, A., Picardi, A., et al. (2012) · Hepatology · doi:10.1002/hep.25930 · Cited by 228 · see citing works

Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose Tissue

Vitseva, O. I., Tanrıverdi, K., Tchkonia, T., Kirkland, J. L., McDonnell, M. E., Apovian, C. M., Freedman, J. E., & Gokce, N. (2008) · Obesity · doi:10.1038/oby.2008.25 · Cited by 215 · see citing works

Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis

Abiru, S., Migita, K., Maeda, Y., Daikoku, M., Ito, M., Ohata, K., Nagaoka, S., Matsumoto, T., Takii, Y., Kusumoto, K., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01191.x · Cited by 209 · see citing works

Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue

Divoux, A., & Clément, K. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00811.x · Cited by 206 · see citing works

Adiponectin: A Key Player in Obesity Related Disorders

Matsuzawa, Y. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208893 · Cited by 203 · see citing works

Targeted Expression of Human Vitamin D Receptor in Adipocytes Decreases Energy Expenditure and Induces Obesity in Mice

Wong, K. E., Kong, J., Zhang, W., Szeto, F. L., Ye, H., Deb, D. K., Brady, M., & Li, Y. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257568 · Cited by 202 · see citing works

Ectopic lipids and organ function.

Szendroedi, J., & Roden, M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328321b3a8 · Cited by 200 · see citing works

Hypoadiponectinemia Predicts the Severity of Hepatic Fibrosis and Pancreatic Beta-Cell Dysfunction in Nondiabetic Nonobese Patients with Nonalcoholic Steatohepatitis

Musso, G., Gambino, R., Biroli, G., Carello, M., Fagà, E., Pacini, G., Michieli, F. D., Cassader, M., Durazzo, M., Rizzetto, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00297.x · Cited by 191 · see citing works

Prevalence of Vitamin D Insufficiency and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls

Goldner, W. S., Stoner, J. A., Thompson, J. S., Taylor, K., Larson, L., Erickson, J. M., & McBride, C. L. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9315-8 · Cited by 190 · see citing works

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway

Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kaneko, K., Okazaki, Y., Bardeesy, N. M., Ohnishi, S., Nagai, R., & Kadowaki, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.131 · Cited by 186 · see citing works

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Finelli, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.802 · Cited by 184 · see citing works

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model

Kamada, Y., Matsumoto, H., Tamura, S., Fukushima, J., Kiso, S., Fukui, K., Igura, T., Maeda, N., Kihara, S., Funahashi, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.020 · Cited by 182 · see citing works

The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases

Tsochatzis, E. A., Papatheodoridis, G., & Archimandritis, A. J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00848.x · Cited by 182 · see citing works

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Barchetta, I., Ben, M. D., Angelico, F., Martino, M. D., Fraioli, A., Torre, G. L., Saulle, R., Perri, L., Morini, S., Tiberti, C., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0638-y · Cited by 181 · see citing works

From fatty liver to fibrosis: A tale of “second hit”

Başaranoğlu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1158 · Cited by 177 · see citing works

Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?

Kwok, R. M., Torres, D. M., & Harrison, S. A. (2013) · Hepatology · doi:10.1002/hep.26390 · Cited by 170 · see citing works

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 168 · see citing works

Correlation of Serum TNF-α Levels and Histologic Liver Injury Scores in Pediatric Nonalcoholic Fatty Liver Disease

Manco, M., Marcellini, M., Giannone, G., & Nobili, V. (2007) · American Journal of Clinical Pathology · doi:10.1309/6vj4dwgydu0xyj8q · Cited by 165 · see citing works

Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently

Beilfuss, A., Sowa, J., Sydor, S., Beste, M., Bechmann, L. P., Schlattjan, M., Syn, W., Wedemeyer, I., Máthé, Z., Jochum, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307024 · Cited by 159 · see citing works

Vitamin D: A new player in non-alcoholic fatty liver disease?

Eliades, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1718 · Cited by 158 · see citing works

1α,25-Dihydroxyvitamin D hydroxylase in adipocytes

Li, J., Byrne, M. E., Chang, E., Jiang, Y., Donkin, S. S., Buhman, K. K., Burgess, J. R., & Teegarden, D. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.09.006 · Cited by 157 · see citing works

Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes

Marcotorchino, J., Gouranton, E., Romier, B., Tourniaire, F., Astier, J., Malezet‐Desmoulins, C., Amiot, M. J., & Landrier, J. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200383 · Cited by 155 · see citing works

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

Park, B. J., Kim, Y. J., Kim, D., Kim, W. K., Jung, Y. J., Yoon, J., Kim, C. Y., Cho, Y. M., Kim, S. H., Lee, K. B., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05212.x · Cited by 154 · see citing works

Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis

Tokushige, K., Takakura, M., Tsuchiya-Matsushita, N., Taniai, M., Hashimoto, E., & Shiratori, K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.028 · Cited by 149 · see citing works

Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease

Lemoine, M., Ratziu, V., Kim, M. J., Maachi, M., Wendum, D., Paye, F., Bastard, J. P., Poupon, R. Y., Housset, C., Capeau, J., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02022.x · Cited by 149 · see citing works

Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms

Videla, L. A. (2009) · World Journal of Hepatology · doi:10.4254/wjh.v1.i1.72 · Cited by 145 · see citing works

25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes

Nimitphong, H., Holick, M. F., Fried, S. K., & Lee, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052171 · Cited by 145 · see citing works

Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats

Nakano, T., Cheng, Y., Lai, C.-Y., Hsu, L., Chang, Y., Deng, J., Huang, Y.-Z., Honda, H., Chen, K., Wang, C., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.028 · Cited by 144 · see citing works

Vitamin D limits inflammation-linked microRNA expression in adipocytes <i>in vitro</i> and <i>in vivo</i>: A new mechanism for the regulation of inflammation by vitamin D

Karkeni, E., Bonnet, L., Marcotorchino, J., Tourniaire, F., Astier, J., Ye, J., & Landrier, J.-F. (2018) · Epigenetics · doi:10.1080/15592294.2016.1276681 · Cited by 142 · see citing works

Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period

Hamabe, A., Uto, H., Imamura, Y., Kusano, K., Mawatari, S., Kumagai, K., Kure, T., Tamai, T., Moriuchi, A., Sakiyama, T., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0376-z · Cited by 140 · see citing works

A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes

Han, S., Li, T., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137 · see citing works

Non-alcoholic steatohepatitis and metabolic syndrome

Machado, M. V., & Cortez‐Pinto, H. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241677.40170.17 · Cited by 133 · see citing works

Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes

Kanemaki, T., Kitade, H., Kaibori, M., Sakitani, K., 平松, 義., Kamiyama, Y., Ito, S., & Okumura, T. (1998) · Hepatology · doi:10.1002/hep.510270515 · Cited by 132 · see citing works

Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?

Nelson, J. E., Roth, C. L., Wilson, L., Yates, K. P., Aouizerat, B. E., Morgan‐Stevenson, V., Whalen, E., Hoofnagle, A. N., Mason, M. J., Gersuk, V. H., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.51 · Cited by 121 · see citing works

Biological Activity of 1,25-Dihydroxyvitamin D3in the Rat1

Tanaka, Y., Frank, H., & DeLuca, H. F. (1973) · Endocrinology · doi:10.1210/endo-92-2-417 · Cited by 117 · see citing works

Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non‐alcoholic fatty liver disease

Dasarathy, J., Periyalwar, P., Allampati, S., Bhinder, V., Hawkins, C., Brandt, P., Khiyami, A., McCullough, A. J., & Dasarathy, S. (2013) · Liver International · doi:10.1111/liv.12312 · Cited by 113 · see citing works

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Vilarrasa, N., Vendrell, J., Maravall, J., Elío, I., Solano, E., San José, P., García, I., Virgili, N., Soler, J., & Gómez, J. M. (2010) · Endocrine · doi:10.1007/s12020-010-9379-4 · Cited by 110 · see citing works

Vitamin D Receptor Gene Expression Is Up-Regulated by 1, 25-Dihydroxyvitamin D3 in 3T3-L1 Preadipocytes

Kamei, Y., Kawada, T., Kazuki, R., Ono, T., Kato, S., & Sugimoto, E. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1717 · Cited by 110 · see citing works

Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease

Nobili, V., Giorgio, V., Liccardo, D., Bedogni, G., Morino, G. S., Alisi, A., & Cianfarani, S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0609 · Cited by 107 · see citing works

High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome

Rhee, E., Kim, M. K., Park, S. E., Park, C., Baek, K. H., Lee, W., Kang, M. I., Park, S., Kim, S.-W., & Oh, K. W. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0387 · Cited by 100 · see citing works

Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD

Gentilucci, U. V., Carotti, S., Perrone, G., Mazzarelli, C., Galati, G., Muda, A. O., Picardi, A., & Morini, S. (2014) · Liver International · doi:10.1111/liv.12531 · Cited by 99 · see citing works

Vitamin D Limits Chemokine Expression in Adipocytes and Macrophage Migration In Vitro and in Male Mice

Karkeni, E., Marcotorchino, J., Tourniaire, F., Astier, J., Peiretti, F., Darmon, P., & Landrier, J. (2015) · Endocrinology · doi:10.1210/en.2014-1647 · Cited by 98 · see citing works

Obesity and NAFLD

Duseja, A. K., & Chawla, Y. K. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.002 · Cited by 95 · see citing works

Effects of the antiprogesterone RU 486 in normal women

Shoupe, D., Mishell, D. R., Page, M. A., Madkour, H., Spitz, I. M., & Løbo, R. A. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80236-3 · Cited by 95 · see citing works

The Independent Association Between 25‐Hydroxyvitamin D and Adiponectin and Its Relation With BMI in Two Large Cohorts: The NHS and the HPFS

Vaidya, A., Williams, J. S., & Forman, J. P. (2011) · Obesity · doi:10.1038/oby.2011.210 · Cited by 93 · see citing works

Adiponectin activation of AMPK disrupts leptin‐mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS‐3)

Handy, J. A., Saxena, N. K., Pingping, F., Lin, S., Mells, J. E., Gupta, N. A., & Anania, F. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22634 · Cited by 91 · see citing works

Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study

Seo, Y. Y., Cho, Y. K., Bae, J.-C., Seo, M. H., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S., & Lee, W. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.1.41 · Cited by 87 · see citing works

Elevated Serum 25(OH)D Concentrations, Vitamin D, and Calcium Intakes Are Associated With Reduced Adipocyte Size in Women

Caron‐Jobin, M., Morisset, A., Tremblay, A., Huot, C., Légaré, D., & Tchernof, A. (2011) · Obesity · doi:10.1038/oby.2011.90 · Cited by 85 · see citing works

Low Levels of 25-Hydroxyvitamin D3 in Children With Biopsy-Proven Nonalcoholic Fatty Liver Disease

Manco, M., Ciampalini, P., & Nobili, V. (2010) · Hepatology · doi:10.1002/hep.23724 · Cited by 85 · see citing works

Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease

Attar, B. M., & Thiel, D. H. V. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/481893 · Cited by 84 · see citing works

Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes

Lorente‐Cebrián, S., Eriksson, A., Dunlop, T. W., Mejhert, N., Dahlman, I. A., Åström, G., Sjölin, E., Wåhlén, K., Carlberg, C., Laurencikiene, J., et al. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0218-z · Cited by 83 · see citing works

Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial

Amiri, H. L., Agah, S., ‌Azar, J. T., Hosseini, S., Shidfar, F., & Mousavi, S. N. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.020 · Cited by 77 · see citing works

Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease

Jablonski, K., Jovanovich, A. J., Holmen, J. R., Targher, G., McFann, K., Kendrick, J., & Chonchol, M. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.12.006 · Cited by 75 · see citing works

Expression of adiponectin and its receptors in livers of morbidly obese patients with non‐alcoholic fatty liver disease

Ma, H., Gómez, V., Lu, L., Yang, X.-J., Wu, X., & Xiao, S. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05548.x · Cited by 72 · see citing works

Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China))

Zhai, H., Wang, N., Han, B., Qin, L., Chen, Y., Zhu, C.-F., Chen, Y., Xia, F., Cang, Z., Zhu, C., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516000386 · Cited by 71 · see citing works

Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients

Barchetta, I., Bernardinis, M. D., Capoccia, D., Baroni, M. G., Fontana, M., Fraioli, A., Morini, S., Leonetti, F., & Cavallo, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068689 · Cited by 64 · see citing works

Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis

Jaruvongvanich, V., Ahuja, W., Sanguankeo, A., Wijarnpreecha, K., & Upala, S. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.02.003 · Cited by 64 · see citing works

Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

Tilg, H. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208929 · Cited by 61 · see citing works

Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model

Kong, M., Zhu, L., Bai, L., Zhang, X., Chen, Y., Liu, S., Zheng, S., Pandol, S. J., Han, Y., & Duan, Z. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00427.2013 · Cited by 59 · see citing works

Starring role of toll-like receptor-4 activation in the gut-liver axis

Carotti, S. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.99 · Cited by 57 · see citing works

Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: Associations with inflammatory and cardiometabolic markers in 4391 subjects

Esteghamati, A., Aryan, Z., Esteghamati, A., & Nakhjavani, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.007 · Cited by 55 · see citing works

Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis

Nannipieri, M., Cecchetti, F., Anselmino, M., Mancini, E., Marchetti, G., Bonotti, A., Baldi, S., Solito, B., Giannetti, M., Pinchera, A., et al. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9701-x · Cited by 53 · see citing works

High-dose vitamin D supplementation and liver histology in NASH

Kitson, M. T., Pham, A., Gordon, A., Kemp, W. W., & Roberts, S. K. (2015) · Gut · doi:10.1136/gutjnl-2015-310417 · Cited by 52 · see citing works

Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss

Popov, V., & Lim, J. K. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00019 · Cited by 46 · see citing works

Obesity and Vitamin D Deficiency

Stokić, E., Kupusinac, A., Tomić-Naglić, D., Kovačev-Zavišić, B., Mitrović, M., Smiljenić, D., Šoškić, S., & Isenović, E. R. (2014) · Angiology · doi:10.1177/0003319714528569 · Cited by 45 · see citing works

A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet

Han, H., Cui, M., You, X., Chen, M., Piao, X., & Jin, G. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.02.011 · Cited by 44 · see citing works

Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis

Zhu, L., Kong, M., Han, Y., Bai, L., Zhang, X., Chen, Y., Zheng, S., Hong, Y., & Duan, Z. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0275 · Cited by 41 · see citing works

Vitamin D and Dysfunctional Adipose Tissue in Obesity

Stokić, E., Kupusinac, A., Tomić-Naglić, D., Smiljenić, D., Kovačev-Zavišić, B., Srdić, B., Šoškić, S., & Isenović, E. R. (2014) · Angiology · doi:10.1177/0003319714543512 · Cited by 41 · see citing works

Prevalence and markers of advanced liver disease in type 2 diabetes

Williamson, R. M., Price, J. F., Hayes, P. C., Glancy, S., Frier, B. M., Johnston, G. I., Reynolds, R. M., Strachan, M. W. J., & on behalf of the Edinburgh Type 2 Diabetes Study Investigators (2011) · QJM · doi:10.1093/qjmed/hcr233 · Cited by 39 · see citing works

Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease

Uribe, M., Zamora‐Valdés, D., Moreno-Portillo, M., Bermejo-Martínez, L., Pichardo-Bahena, R., González, H. A. B., Ponciano‐Rodríguez, G., Uribe, M. H., Medina‐Santillán, R., & Méndez‐Sánchez, N. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31890-3 · Cited by 38 · see citing works

The relationship between vitamin D and obesity

Šoškić, S., Stokić, E., & Isenović, E. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.900004 · Cited by 35 · see citing works

Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.

Arvaniti, V., Thomopoulos, K., Tsamandas, A. C., Makri, M. G., Psyrogiannis, A. I., Vafiadis, G., Assimakopoulos, S. F., Asimakopoulos, S., & Labropoulou-Karatza, C. (2008) · PubMed · Cited by 34 · see citing works

Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study

Wang, D., Lin, H., Xia, M., Aleteng, Q., Li, X., Ma, H., Pan, B., Gao, J., & Gao, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157515 · Cited by 31 · see citing works

Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, São Paulo, Brazil

de Souza, W. N., Norde, M. M., Oki, É., Rogero, M. M., Marchioni, D. M. L., Fisberg, R. M., & Martini, L. A. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.006 · Cited by 30 · see citing works

Interrogation of microarray datasets indicates that macrophage-secreted factors stimulate the expression of genes associated with vitamin D metabolism (VDR and CYP27B1) in human adipocytes

Trayhurn, P., O'Hara, A., & Chen, B. (2011) · Adipobiology · doi:10.14748/adipo.v3.269 · Cited by 28 · see citing works

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin

Pοlyzos, S. A., Kountouras, J., Zavos, C., Stergiopoulos, C., & Pοlyzos, S. A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.12.028 · Cited by 26 · see citing works

Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?

Ding, N., Liddle, C., Evans, R. M., & Downes, M. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.841078 · Cited by 26 · see citing works

TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis

Alaaeddine, N., Sidaoui, J., Hilal, G., Serhal, R., Abedelrahman, A., & Khoury, S. E. (2012) · European Cytokine Network · doi:10.1684/ecn.2012.0313 · Cited by 24 · see citing works

Adiponectin and Alcoholic Fatty Liver: Is It, After All, About What You Eat? * #

Anania, F. A. (2005) · Hepatology · doi:10.1002/hep.20861 · Cited by 18 · see citing works

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update

Barchetta, I., Cimini, F. A., & Cavallo, M. G. (2020) · Nutrients · doi:10.3390/nu12113302 · Cited by 188 · see citing works

Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease

Chen, Q., Hu, P., Hou, X., Sun, Y., Jiao, M., Peng, L., Dai, Z., Yin, X., Liu, R., Li, Y., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02343-7 · Cited by 135 · see citing works

Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution

Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K., & Jensen, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.737709 · Cited by 112 · see citing works

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future

Barchetta, I., Cimini, F. A., & Cavallo, M. G. (2017) · Nutrients · doi:10.3390/nu9091015 · Cited by 86 · see citing works

Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities

Hyppönen, E., & Boucher, B. J. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy034 · Cited by 82 · see citing works

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients

Federico, A., Dallio, M., Masarone, M., Gravina, A. G., Sarno, R. D., Tuccillo, C., Cossiga, V., Lama, S., Stiuso, P., Morisco, F., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8742075 · Cited by 68 · see citing works

Vitamin D Supplementation Improves Adipose Tissue Inflammation and Reduces Hepatic Steatosis in Obese C57BL/6J Mice

Marziou, A., Philouze, C., Couturier, C., Astier, J., Obert, P., Landrier, J., & Riva, C. (2020) · Nutrients · doi:10.3390/nu12020342 · Cited by 65 · see citing works

Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease

Yan, H., Yan-qiong, G., Zhang, Y., Wang, H., Liu, G., & Lei, J.-Y. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9746-5 · Cited by 61 · see citing works

Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis

Wang, N., Chen, C., Zhao, L., Chen, Y., Han, B., Xia, F., Cheng, J., Li, Q., & Lu, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.027 · Cited by 60 · see citing works

The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review

Abe, R. A. M., Masroor, A., Khorochkov, A., Prieto, J., Singh, K. B., Nnadozie, M. C., Abdal, M., Shrestha, N., & Mohammed, L. (2021) · Cureus · doi:10.7759/cureus.16855 · Cited by 55 · see citing works

Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?

Turner, L., Wanasinghe, A. I., Brunori, P., & Santosa, S. (2025) · Obesity Reviews · doi:10.1111/obr.13956 · Cited by 58 · see citing works

Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study

Liu, S., Liu, Y., Wan, B., Zhang, H., Wu, S., Zhu, Z., Lin, Y., Wang, M.-F., Zhang, N., Lin, S., et al. (2019) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.65.303 · Cited by 50 · see citing works

Obesity-Induced Vitamin D Deficiency Contributes to Lung Fibrosis and Airway Hyperresponsiveness

Han, H., Chung, S. I., Park, H. J., Oh, E. Y., Kim, S., Park, K. H., Lee, J.-H., & Park, J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0086oc · Cited by 45 · see citing works

Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease

Ravaioli, F., Pivetti, A., Marco, L. D., Chrysanthi, C., Frassanito, G., Pambianco, M., Sicuro, C., Gualandi, N., Guasconi, T., Pecchini, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169016 · Cited by 42 · see citing works

Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway

Yan, B., Wang, Y., Wang, W., Ding, X., Wei, B., Liu, S., Fu, T., Chen, L., Zhang, J.-Z., Liu, J., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115999 · Cited by 40 · see citing works

Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction–associated fatty liver disease: a prospective cohort study

Zhang, J.-J., Yu, H., Li, Y., Zhang, Y., Geng, T., Lu, Q., Liao, Y.-F., Guo, K., Du, L., Ruan, H.-L., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac260 · Cited by 38 · see citing works

Association between inflammation, oxidative stress, vitamin D, copper and zinc with pre-obesity and obesity in school children from the city of Podgorica, Montenegro

Jakšić, M., Martinović, M., Barhanovic, N. G., Vujacic, A., Djurović, D., & Nedović-Vuković, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0086 · Cited by 38 · see citing works

Vitamin D Deficiency Increases Lipogenesis and Reduces Beta-Oxidation in the Liver of Diet-Induced Obese Mice

Borges, C. C., Salles, A. F., Bringhenti, I., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2018) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.64.106 · Cited by 37 · see citing works

Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score

Yeo, C., Ong, W. M., Cheng, K. S. A., & Tan, C. H. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03676-5 · Cited by 36 · see citing works

Relationship between hepatic and systemic angiopoietin‐like 3, hepatic Vitamin D receptor expression and NAFLD in obesity

Barchetta, I., Cimini, F. A., Chiappetta, C., Bertoccini, L., Ceccarelli, V., Capoccia, D., Gaggini, M., Cristofano, C. D., Rocca, C. D., Silecchia, G., et al. (2020) · Liver International · doi:10.1111/liv.14554 · Cited by 37 · see citing works

The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily

Oppedisano, F., Muscoli, C., Musolino, V., Carresi, C., Giancotta, C., Bosco, F., Maiuolo, J., Scarano, F., Macrì, R., Paone, S., et al. (2020) · Nutrients · doi:10.3390/nu12051435 · Cited by 34 · see citing works

Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review

von Hafe, M., Borges‐Canha, M., Vale, C., Leite, A. R., Neves, J. S., Carvalho, D. M., & Leite-Moreira, A. F. (2022) · Metabolites · doi:10.3390/metabo12040298 · Cited by 34 · see citing works

Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis

Liu, T., Xu, L., Chen, F., & Zhou, Y.-B. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001486 · Cited by 33 · see citing works

Effects of vitamin D supplementation on insulin resistance and dyslipidemia in overweight and obese premenopausal women

İmga, N. N., Karcı, A. Ç., Öztaş, D., Berker, D. S., & Güler, S. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.75864 · Cited by 31 · see citing works

Obesity and micronutrients deficit, when and how to suplement

Chapela, S. P., Martinuzzi, A. L. N., Llobera, N. D., Ceriani, F., González, V. C., Montalván, M., Verde, L., & Frías-Toral, E. (2024) · Food and Agricultural Immunology · doi:10.1080/09540105.2024.2381725 · Cited by 29 · see citing works

The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review

Mohammadian, K., Fakhar, F., Keramat, S., & Stanek, A. (2024) · Antioxidants · doi:10.3390/antiox13070797 · Cited by 28 · see citing works

The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review

Giuffrè, M., Merli, N., Pugliatti, M., & Moretti, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063337 · Cited by 29 · see citing works

Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1

Chen, K., Lin, T., Yao, W., Chen, X., Xiong, X., & Huang, Z. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.12.003 · Cited by 26 · see citing works

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease

Dibba, P., Li, A. A., Cholankeril, G. T., Iqbal, U., Gadiparthi, C., Khan, M. A., Kim, D., & Ahmed, A. (2018) · Medicines · doi:10.3390/medicines5020047 · Cited by 26 · see citing works

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease

Federico, A., Dallio, M., Gravina, A. G., Diano, N., Errico, S., Masarone, M., Romeo, M., Tuccillo, C., Stiuso, P., Morisco, F., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103369 · Cited by 25 · see citing works

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Bellan, M., Colletta, C., Barbaglia, M. N., Salmi, L., Clerici, R., Mallela, V. R., Castello, L. M., Saglietti, G., Schianca, G. P. C., Minisini, R., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0201 · Cited by 25 · see citing works

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity

Borges‐Canha, M., Neves, J. S., Mendonça, F. M., Silva, M. M., Costa, C. F., Cabral, P. M., Guerreiro, V. A., Lourenço, R., Meira, P., Salazar, D. A., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286334 · Cited by 25 · see citing works

Apolipoprotein O expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial function

Tian, F., Wu, C., Yu, B., Liu, L., & Hu, J.-R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.128 · Cited by 21 · see citing works

Gestational exposure to bisphenol S induces microvesicular steatosis in male rat offspring by modulating metaflammation

Molangiri, A., Varma, S., Hridayanka, K. S. N., Srinivas, M., Kona, S. R., Ibrahim, A., Duttaroy, A. K., & Basak, S. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.166775 · Cited by 18 · see citing works

Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease

Liu, J., Song, Y., Ye, W., & Hong, H. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2274099 · Cited by 18 · see citing works

Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults

Liu, C., Sun, X., Peng, J., Yu, H., Lu, J., & Feng, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-52077-5 · Cited by 17 · see citing works

Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis

Wang, Y., Liang, K., & Kong, W.-Z. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.03.004 · Cited by 17 · see citing works

Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic Review

Seaw, K. M., Henry, C. J., & Bi, X. (2023) · Livers · doi:10.3390/livers3030033 · Cited by 16 · see citing works

Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice

Quesada‐Vázquez, S., Colom‐Pellicer, M., Navarro‐Masip, È., Aragonès, G., Bas-Prior, J. M. D., Caimari, A., & Escoté, X. (2021) · Nutrients · doi:10.3390/nu13103532 · Cited by 16 · see citing works

Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children

Hua, M., Huang, J., Hu, C., Yao, T., & Lai, M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00420 · Cited by 15 · see citing works

The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter

Heo, N. J., Park, H. E., Yoon, J. W., Kwak, M., Yang, J. I., Chung, S. J., Yim, J. Y., & Chung, G. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122611 · Cited by 15 · see citing works

Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D

Khan, S. A., Ali, A., Khan, S., Bakillah, A., Damanhouri, G. A., Khan, A., Makki, A., AlAnsari, I., & Banu, N. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0251-5 · Cited by 15 · see citing works

Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time

Falalyeyeva, T. M., Komisarenko, I., Yanchyshyn, A., Kovalchuk, O. I., Lozko, Y., Tsyryuk, O., Fagoonee, S., & Kobyliak, N. M. (2021) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.21.02766-x · Cited by 14 · see citing works

Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study

Wang, M., Zhang, R., Wang, M., Zhang, L., Ding, Y., Tang, Z., Wang, H., Zhang, W., Chen, Y., & Wang, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.717533 · Cited by 14 · see citing works

Vitamin D 1,25-Dihydroxyvitamin D3 reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization

Luo, W., Dong, X., Ye, H., Zhao, Q.-S., Zhang, Q., Guo, W., Liu, H., & Xu, F. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i12.4685 · Cited by 14 · see citing works

Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India

Kumar, M., Parchani, A., Kant, R., & Das, A. K. (2023) · Cureus · doi:10.7759/cureus.34921 · Cited by 13 · see citing works

Down Syndrome and Pediatric Nonalcoholic Fatty Liver Disease: A Causal or Casual Relationship?

Matteo, A. D., & Vajro, P. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.07.011 · Cited by 13 · see citing works

Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women

Machado, M. D. G. P., Almeida-Filho, B. D. S., Véspoli, H. D. L., Schmitt, E. B., Nahás-Neto, J., & Nahás, E. A. P. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001203 · Cited by 13 · see citing works

Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes

Zupo, R., Castellana, F., Panza, F., Castellana, M., Lampignano, L., Cincione, R. I., Triggiani, V., Giannelli, G., Dibello, V., Sardone, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081695 · Cited by 13 · see citing works

Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ12,14PGJ2

Ayyash, A., & Holloway, A. C. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4272 · Cited by 13 · see citing works

Procollagen‐III peptide identifies adipose tissue‐associated inflammation in type 2 diabetes with or without nonalcoholic liver disease

Barchetta, I., Cimini, F. A., Gioannis, R. D., Ciccarelli, G., Bertoccini, L., Lenzi, A., Baroni, M. G., & Cavallo, M. G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2998 · Cited by 13 · see citing works

The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency

Tattoli, I., Mathew, A. R., Verrienti, A., Pallotta, L., Severi, C., Andreola, F., Cavallucci, V., Giorgi, M., Massimi, M., Bencini, L., et al. (2024) · Cells · doi:10.3390/cells13191631 · Cited by 12 · see citing works

Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM

Hosny, S. S., Ali, H. M., Mohammed, W. A., & Ghannam, M. H. E. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.002 · Cited by 12 · see citing works

Quercetin improved hepatic circadian rhythm dysfunction in middle-aged mice fed with vitamin D-deficient diet

Li, R., Wang, G., Liu, R., Luo, L., Zhang, Y., & Wan, Z. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00990-0 · Cited by 11 · see citing works

Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease

Abdelrahman, B. A., El-Khatib, A. S., & Attia, Y. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122124 · Cited by 10 · see citing works

Low prevalence of vitamin D deficiency in adult residents in Hainan, the tropical island province of China

Lin, L., Ou, Q., Lü, L., Zhang, H., Chen, K., Chen, D., Quan, H., He, Y., & Fang, T. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1033 · Cited by 10 · see citing works

Relationship between Serum 25-hydroxy-vitamin D Concentration and Risk of Metabolic Syndrome in Patients with Fatty Liver

Lim, H., Kim, T., Lee, H., Kim, S.-K., Lee, B., & Park, Y. H. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.4.223 · Cited by 9 · see citing works

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

Dibba, P., Li, A. A., Cholankeril, G. T., Khan, M. A., Kim, D., & Ahmed, A. (2019) · Nutrition and Metabolic Insights · doi:10.1177/1178638819847480 · Cited by 9 · see citing works

Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective

Mărginean, C. M., Pîrșcoveanu, D. F. V., Cazacu, S. M., Popescu, M. S., Mărginean, I. C., Iacob, G. A., & Popescu, M. (2024) · Gastroenterology Insights · doi:10.3390/gastroent15040071 · Cited by 10 · see citing works

Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF‐κB ligand in nonalcoholic fatty liver disease

Nikseresht, M., Azarmehr, N., Arya, A., Alipoor, B., Fadaei, R., Khalvati, B., Abidi, H., & Doustimotlagh, A. H. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2047 · Cited by 7 · see citing works

SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice

Tran, M., Mostofa, G., Picard, M., Wu, J., Wang, L., & Shin, D. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0073 · Cited by 7 · see citing works

Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease

Dong, W., Jin, Y., Shi, H., Zhang, X., Chen, J., Jia, H., & Zhang, Y. (2023) · Medicine · doi:10.1097/md.0000000000033912 · Cited by 7 · see citing works

Fetuin B links vitamin D deficiency and pediatric obesity: Direct negative regulation by vitamin D

Walker, G. E., Follenzi, A., Bruscaggin, V., Manfredi, M., Bellone, S., Marengo, E., Maiuri, L., Prodam, F., & Bona, G. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.009 · Cited by 7 · see citing works

Vitamin D Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obesity Murine Model

Chung, S. I., Liang, L., Han, H., Park, K. H., Lee, J.-H., & Park, J. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2024.0038 · Cited by 6 · see citing works

Vitamin D Status and Its Correlation With Anthropometric and Biochemical Indicators of Cardiometabolic Risk in Serbian Underground Coal Miners in 2016

Šarac, I., Jovanović, J., Zec, M. M., Pavlović, Z., Debeljak-Martačić, J., Zeković, M., Milešević, J. P., Gurinović, M. A., & Glibetić, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.689214 · Cited by 5 · see citing works

Vitamin D in women with class II/III obesity: Findings from the DieTBra trial

Silveira, É. A., Silveira, L. C., Cardoso, C. K. D. S., Schmidt, A., Santos, A. S. E. A. D. C., de Oliveira, C. M., & Vitorino, P. V. D. O. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.02.027 · Cited by 5 · see citing works

Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease

Qu, Y., Yh, S., Sun, R., Ma, Y., & Zhang, Y. (2024) · Physiological Research · doi:10.33549/physiolres.935164 · Cited by 4 · see citing works

Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet

Jin, M., Niu, X., Liu, Y., Zhang, D., Yuan, D., & Shen, H. (2020) · Open Medicine · doi:10.1515/med-2020-0212 · Cited by 4 · see citing works

Relationship between vitamin D deficiency and metabolic disorders

Tsyryuk, O., Tseyslyer, Y. V., Strubchevska, K., Kozyk, M., Ostapchenko, D., Korotkyi, O., & Tymoshenko, I. O. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.1.2023.1241 · Cited by 4 · see citing works

The interplay between childhood obesity and vitamin D deficiency: mechanisms and implications

Zhou, X., Chen, Y., Xu, J., Li, X., Wu, Y., & Xu, L. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1700949 · Cited by 3 · see citing works

Prognostic value of atherogenic index of plasma on the all-cause and causes-specific mortality among patients with metabolic dysfunction-associated steatotic liver disease

Song, G., Chu, H., Liu, Y., Liu, X., & Gu, R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01800-x · Cited by 3 · see citing works

From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease

Liu, Q., & Niu, C.-Y. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i19.1171 · Cited by 3 · see citing works

Relationship between level of serum VIT D and insulin resistance in patients with MAFLD

Hassnine, A. A., Elsayed, A. M., Abdelaziez, S. K., Higazi, M. M., Okaily, N. I., & Soliman, W. T. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01820-0 · Cited by 2 · see citing works

Metabolic Dysfunction Associated Steatotic Liver Disease and Bone Turnover Markers in Postmenopausal Women: A Cross‐Sectional Study in Central Nepal

Maharjan, S., Dahal, P., Ranabhat, B., & Shakya, J. (2026) · Health Science Reports · doi:10.1002/hsr2.71777 · Cited by 2 · see citing works

Prevalence of vitamin D deficiency in Libya and its relation to other health disorders

Younis, M. Y. G. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.36 · Cited by 2 · see citing works

Vitamin D improves lipid profile and promotes beneficial effects of aerobic training in elderly women with NAFLD

Hoseini, Z., Behpoor, N., & Hoseini, R. (2020) · Science & Sports · doi:10.1016/j.scispo.2020.03.003 · Cited by 2 · see citing works

Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1

Chen, K., Lin, T., Yao, W., Chen, X., Xiong, X., & Huang, Z. (2023) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.12.002 · Cited by 2 · see citing works

Association between circulating biomarkers and non-alcoholic fatty liver disease: An integrative Mendelian randomization study of European ancestry

Chen, D., Zhang, Y., Zhou, Y., & Liu, Y. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.09.016 · Cited by 1 · see citing works

The level of serum C-peptide signals fibrosis in obese patients with NAFLD

Fawzi, M. M., Aziz, G. R. A. E., Mohamed, R. A. E. D., Kamal, M. M., & Shenawy, A. E. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00497-8 · Cited by 1 · see citing works

Tissue engineered models of adipose tissue dysfunction to investigate obesity-related comorbidities

Celebi, L. E., Ketchum, F., Bozkaya, D. N., & Zorlutuna, P. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae1cfe · Cited by 3 · see citing works

Impact of bariatric surgery on metabolic-dysfunction associated fatty liver disease in diabetic and non-diabetic patients: a cohort study

Sistanizad, M., Taherpour, N., Alibeigi, P., Sadeghi, S., Shamizadehkalkhoran, M., & Moradi, O. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04524-4 · Cited by 1 · see citing works

The Yin and Yang of tertiary lymphoid structures in primary liver cancer

Liu, H., Chen, S., Cao, M., Shu, L., Ji, M., Zhou, J., Fan, J., Wang, P., & Sun, Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218461 · Cited by 1 · see citing works

Evaluation of Adiponectin, Irisin, Vitamin D Levels and Their Relation in Iraqi Patients with Non alcoholic Fatty Liver Disease

Sattar, A. A. F., & AL-Sa’adi, W. T. (2023) · Ibn AL- Haitham Journal For Pure and Applied Science · doi:10.30526/36.2.3043 · Cited by 1 · see citing works

Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease

Zhang, J. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i3.102424 · Cited by 1 · see citing works

Association of Age and Serum Vitamin D Levels in Men with Metabolic Syndrome

Qahwaji, D. M. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.03.298 · Cited by 1 · see citing works

Clinical Manifestations of Liver Disease in Diabetes Mellitus

Virović-Jukić, L., Forgač, J., Ogresta, D., Filipec-Kanižaj, T., & Mrzljak, A. (2018) · Clinical gastroenterology · doi:10.1007/978-3-319-75856-5_21

Comparison of Prediction Equations for Resting Energy Expenditure vs the KORR ReeVue Indirect Calorimeter in Obesity

Petersen, C. (2018) · KU ScholarWorks (The University of Kansas)

Correction of insulin resistance in patients with nonalcoholic fatty liver disease with overweight and obesity

Pivtorak, K. V., Shevchuk, N. А., & Pivtorak, N. (2019) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xxiii.3.91.2019.66

Steatohepatitis in Children with Obesity

Zvyagin, A. A., Fateeva, N. Y., Chubarov, T. V., & Zhdanova, O. A. (2021) · Вопросы современной педиатрии · doi:10.15690/vsp.v20i3/2275

Do serum vitamin D levels affect liver enzymes in insulin resistance and obesity patients?

Özkan, G. Ö. (2022) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.21.04661-1

VITAMINA D NO TRATAMENTO DE ESTEATO-HEPATITE NÃO-ALCOÓLICA: UMA REVISÃO INTEGRATIVA

SÁ, A. R. A., da SILVA, C. P., & dos Santos, A. C. O. (2022) · Unifunec Científica Multidisciplinar · doi:10.24980/ucm.v11i13.5628

Study on the effect of vitamin D on obesity and fatty liver induced by monosodium glutamate in male albino rats

Shakour, S. Y. H., Barhoma, R. A., Tahoon, N., & Elshrbiny, R. A. (2022) · Tanta Medical Journal · doi:10.4103/tmj.tmj_75_21

Gestational exposure to bisphenol S induces microvesicular steatosis by promoting lipogenesis and inflammation in male rat offspringPreprint

Molangiri, A., Varma, S., Hridayanka, K. S. N., Srinivas, M., Kona, S. R., Ibrahim, A., Duttaroy, A. K., & Basak, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.543354

FIB 4 Score (Liver Fibrosis) and Attending Level of Vitamin D in Chronic Hepatitis C Patients

Sami, T., Kammeruddin, K., Imran, M., Ali, M., Rahman, N., Waheed, S. A., Ali, J., Bibi, A., Latif, A., & Mazher, S. (2023) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v4i06.811

Einfluss des Optifast-52-Programms auf den Leberfibrosegrad von Patienten mit Adipositas

Gummlich, B. P. M. (2023) · doi:10.53846/goediss-10189

Supplementation with optimized multivitamin premix relieves liver steatosis by inhibiting CD36 palmitoylation and regulating intestinal microorganisms in largemouth bass (Micropterus salmoides)

Hua, L., Liu, H., Xin, M., Zhang, Z., Xiao, X., Han, D. H., Zhu, X., Jin, J., Yang, Y., & Xie, S. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102098

Plant-Based Retinol Intake and Risk of Nonalcoholic Fatty Liver Disease in American Adults: Insights from NHANES 2007-2014

Liu, C., Bai, Z., & Cheng, J. (2025) · World Journal of Public Health · doi:10.11648/j.wjph.20251003.29

Arjunolic acid from Cyclocarya paliurus as a pleiotropic phytochemical effectively counteracts the “multiple parallel hits” in non-alcoholic fatty liver disease

Zheng, X., Zhang, X., Zhang, J., Pan, K., Yan, B., & Yin, Z. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106993

Prevalence and clinical correlates of overweight and obesity among adults in Abha, Saudi Arabia: A retrospective cross-sectional study

AlSamghan, A. S., Mahmood, S. E., Ahmad, A., & Alsaleem, M. A. (2025) · Medicine · doi:10.1097/md.0000000000045804

Effet combiné de l’exercice physique et de la vitamine D en prévention tertiaire sur des souris c57bl/6j soumises à un régime riche en graisse et en sucre : aspects métaboliques de l’obésité et des désordres associés

Marziou, A. (2021) · theses.fr (ABES) · doi:10.70675/5ac5d7aez174dz4164z86fbze535a2a8522a

Molecular Crosstalk Between Vitamin D and Non-alcoholic Fatty Liver Disease

Sarkar, S. (2023) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2023.00019 · Cited by 5 · see citing works

Vitamin D: A new player in non-alcoholic fatty liver disease?

Eliades, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1718 · Cited by 158 · see citing works

Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?

Kwok, R. M., Torres, D. M., & Harrison, S. A. (2013) · Hepatology · doi:10.1002/hep.26390 · Cited by 170 · see citing works

VITAMIN D AND FATTY LIVER DISEASE: PATHOPHYSIOLOGICAL LINKS AND THERAPEUTIC POTENTIAL

(2025) · National Journal of Biological Sciences · doi:10.37605/v6i2/3

Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables

Pacifico, L., Osborn, J. F., Bonci, E., Pierimarchi, P., & Chiesa, C. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666181025153712 · Cited by 46 · see citing works